Literature DB >> 19470715

Use of reduced temperature cell pausing to enhance flexibility of cell-based assays.

Helen Wise1, Paul William Abel, Darren Cawkill.   

Abstract

Construction and supply of cell-based reagents for in vitro plate-based screens are often highlighted as a bottleneck within drug discovery. Recent years have seen the successful application of both cryopreservation and automation to increase the capacity and flexibility of cell provision. However, routine cell culture remains a fixed experimental process that requires cells to be prepared and used at specific times. We have investigated the potential of reduced temperature incubation to be used as a simple methodology for stopping and starting cell growth and introduce further flexibility into cell provision. Our results show that incubation of CHOK1, HEK293, and 1321N1 cells at 23 degrees C arrested growth while maintaining cell viability. Recovery of these paused cells at 37 degrees C resulted in resumption of normal cell growth and target protein function. Experiments demonstrated that paused cells, expressing either a recombinant G-protein-coupled receptor or an ion channel, performed comparably with the equivalent continuously cultured cells in a 384-well cell-based assay. This simple technique offers the potential to introduce flexibility into cell culture experiments and processes that were previously considered to be fixed.

Mesh:

Substances:

Year:  2009        PMID: 19470715     DOI: 10.1177/1087057109335748

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  2 in total

1.  Strategies for the hypothermic preservation of cell sheets of human adipose stem cells.

Authors:  Sara Freitas-Ribeiro; Andreia Filipa Carvalho; Marina Costa; Mariana Teixeira Cerqueira; Alexandra Pinto Marques; Rui Luís Reis; Rogério Pedro Pirraco
Journal:  PLoS One       Date:  2019-10-15       Impact factor: 3.240

2.  Aggravation of cold-induced injury in Vero-B4 cells by RPMI 1640 medium - identification of the responsible medium components.

Authors:  Gesine Pless-Petig; Martin Metzenmacher; Tobias R Türk; Ursula Rauen
Journal:  BMC Biotechnol       Date:  2012-10-10       Impact factor: 2.563

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.